Veru's Covid-19 drug lowers mortality by 55% in Phase III trial

Veru has reported interim analysis data from a Phase III trial, where sabizabulin lowered mortality by 55% in hospitalised Covid-19 patients.

Related Keywords

Bulgaria ,Mexico ,Colombia ,Argentina ,Brazil ,Mitchell Steiner ,Contract Manufacturing Organisation ,Contract Research Organisation For Clinical Trials ,Data Safety Monitoring Committee ,Drug Administration ,Independent Data Safety Monitoring Committee ,Research Organisation ,Preference Management Solution ,Manufacturing Organisation ,Pharmaceutical Supply ,